Klinische Studie

Pharmacologic Augmentation of TMS for Depression With D-serine

NCT: NCT06876129 · RECRUITING

NCT-IDNCT06876129

Medizinische Daten: StatusRECRUITING

Startdatum2025-04-01

Abschluss2027-04-01

SponsorMclean Hospital (OTHER)

First posted2025-03-14

Last updated2026-05-15

Kurzzusammenfassung

The goal of this study is to test whether combining D-serine with 30 treatments of a) iTBS and b) 18-Hz protocols will enhance clinical outcomes compared to rTMS with placebo (i.e., sugar pill). The investigators hypothesize that NMDA receptor activation via D-serine combined with repeated sessions of rTMS will produce greater clinical outcomes than iTBS with placebo and 18-Hz with placebo.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.